Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109613

Isolation and Characterization of Heparin from Human Lung

Dean D. Metcalfe, Robert A. Lewis, Jeremiah E. Silbert, Robert D. Rosenberg, Stephen I. Wasserman, and K. Frank Austen

Departments of Medicine, Harvard Medical School and the Robert B. Brigham Division of the Affiliated Hospitals Center, Inc., Boston, Massachusetts 02120

Connective Tissue-Aging Research Laboratory, Veterans Administration Outpatient Clinic and Tufts University School of Medicine, Boston, Massachusetts 02120

Beth Israel Hospital and Sidney Farber Cancer Institute, Boston, Massachusetts 02120

Find articles by Metcalfe, D. in: JCI | PubMed | Google Scholar

Departments of Medicine, Harvard Medical School and the Robert B. Brigham Division of the Affiliated Hospitals Center, Inc., Boston, Massachusetts 02120

Connective Tissue-Aging Research Laboratory, Veterans Administration Outpatient Clinic and Tufts University School of Medicine, Boston, Massachusetts 02120

Beth Israel Hospital and Sidney Farber Cancer Institute, Boston, Massachusetts 02120

Find articles by Lewis, R. in: JCI | PubMed | Google Scholar

Departments of Medicine, Harvard Medical School and the Robert B. Brigham Division of the Affiliated Hospitals Center, Inc., Boston, Massachusetts 02120

Connective Tissue-Aging Research Laboratory, Veterans Administration Outpatient Clinic and Tufts University School of Medicine, Boston, Massachusetts 02120

Beth Israel Hospital and Sidney Farber Cancer Institute, Boston, Massachusetts 02120

Find articles by Silbert, J. in: JCI | PubMed | Google Scholar

Departments of Medicine, Harvard Medical School and the Robert B. Brigham Division of the Affiliated Hospitals Center, Inc., Boston, Massachusetts 02120

Connective Tissue-Aging Research Laboratory, Veterans Administration Outpatient Clinic and Tufts University School of Medicine, Boston, Massachusetts 02120

Beth Israel Hospital and Sidney Farber Cancer Institute, Boston, Massachusetts 02120

Find articles by Rosenberg, R. in: JCI | PubMed | Google Scholar

Departments of Medicine, Harvard Medical School and the Robert B. Brigham Division of the Affiliated Hospitals Center, Inc., Boston, Massachusetts 02120

Connective Tissue-Aging Research Laboratory, Veterans Administration Outpatient Clinic and Tufts University School of Medicine, Boston, Massachusetts 02120

Beth Israel Hospital and Sidney Farber Cancer Institute, Boston, Massachusetts 02120

Find articles by Wasserman, S. in: JCI | PubMed | Google Scholar

Departments of Medicine, Harvard Medical School and the Robert B. Brigham Division of the Affiliated Hospitals Center, Inc., Boston, Massachusetts 02120

Connective Tissue-Aging Research Laboratory, Veterans Administration Outpatient Clinic and Tufts University School of Medicine, Boston, Massachusetts 02120

Beth Israel Hospital and Sidney Farber Cancer Institute, Boston, Massachusetts 02120

Find articles by Austen, K. in: JCI | PubMed | Google Scholar

Published December 1, 1979 - More info

Published in Volume 64, Issue 6 on December 1, 1979
J Clin Invest. 1979;64(6):1537–1543. https://doi.org/10.1172/JCI109613.
© 1979 The American Society for Clinical Investigation
Published December 1, 1979 - Version history
View PDF
Abstract

Heparin as measured by azure A metachromasia and anticoagulant activity has been extracted with 1 M NaCl from 35S-labeled human lung fragments or dispersed human lung cells enriched for mast cells. The 35S-labeled metachromatic material in the 3 M NaCl eluate from Dowex-1 chromatography of the extract from lung fragments exhibited an average mol wt of 20,000 by Sepharose 4B gel filtration. The 35S-labeled metachromatic material with the charge characteristics of commercial porcine heparin on DEAE cellulose chromatography was entirely heparin by the criteria of resistance to degradation by chondroitin ABC lyase and complete degradation by purified heparinase. Antithrombin affinity chromatography of purified heparin with an anticoagulant activity of 137 U/mg, revealed that the one-third that was bound and eluted had a 273 U/mg sp act, whereas the unbound activity was 31 U/mg. Thus, the previously observed heterogeneity of commercial porcine heparin for binding to human antithrombin was also observed with human heparin. The mast cell-enriched human lung cell preparations yielded [35S]mucopolysaccharides with an average mol wt of 60,000 by Sepharose 4B gel filtration. Approximately 30% of this fraction was degraded by chondroitin ABC lyase, and the residual 70% was degraded by purified heparinase. When the chondroitin ABC lyase-resistant fraction was subjected to alkali degradation the average mol wt was reduced to 20,000. The calculated human lung mast cell heparin content of 2.4-7.8 μg/106 cells gave a ratio to histamine on a weight basis similar to that of intact lung fragments, thereby implying that heparin in the lung fragments was largely restricted to the mast cells.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1537
page 1537
icon of scanned page 1538
page 1538
icon of scanned page 1539
page 1539
icon of scanned page 1540
page 1540
icon of scanned page 1541
page 1541
icon of scanned page 1542
page 1542
icon of scanned page 1543
page 1543
Version history
  • Version 1 (December 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts